Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein Discovery™. Through our technology, we accelerate breakthrough improvements in human health and empower life science researchers with easy access to target proteins.
Nuclera was founded in 2013 by PhD students at the University of Cambridge. When working on their dissertations, they identified protein inaccessibility as the number one obstacle and a key bottleneck in biology.
They set out to solve protein inaccessibility in an effort to better human health. This drive feeds into the company’s vision to deliver the first thought-to-protein prototyping system that reduces the timelines and hurdles to acquire target proteins in drug discovery programs.
eProtein Discovery
Express protein on your own terms
Nuclera’s eProtein Discovery is a benchtop system combining digital microfluidics alongside in situ protein detection assays and cell-free protein synthesis.
The eProtein Discovery™ solution, including integrated eProtein Discovery Software, gets protein in your hand quicker than ever before. With our cell-free protein synthesis reagents and microfluidics-based eProtein Discovery™ cartridges, it all happens on your own benchtop, in your way.
DOWNLOAD BROCHURES FOR MORE INFORMATION
Nuclera’s solution to protein discovery
Introducing eProtein Discovery
Functional membrane proteins in 48 hrs